⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNA News
Avidity Biosciences, Inc. Common Stock
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
prnewswire.com
RNA
Avidity Biosciences Announces Proposed Public Offering of Common Stock
prnewswire.com
RNA
Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44
prnewswire.com
RNA